Company Data
Tiziana Life Sciences Ltd
Ticker
TLSA
Current Price
$1.05
Market Cap
$133.6M
Price Target
Refer to Report
Volume
264.4K
52wk Range
$0.7615 - $2.2
Overview
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for autoimmune and inflammatory diseases, degenerative diseases, and cancer-related to the liver. Its clinical pipeline includes drug assets for Crohn’s Disease, COVID19, Secondary Progressive Multiple Sclerosis, and Hepatocellular Carcinoma. Its development pipeline includes Foralumab, Milciclib, Anti-IL6R, and Others. The company has a single reporting segment, which is the research and development of biotechnological & pharmaceutical products.